781 related articles for article (PubMed ID: 24552665)
1. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
Taniguchi K; Karin M
Semin Immunol; 2014 Feb; 26(1):54-74. PubMed ID: 24552665
[TBL] [Abstract][Full Text] [Related]
2. Gene of the month: Interleukin 6 (IL-6).
Ataie-Kachoie P; Pourgholami MH; Richardson DR; Morris DL
J Clin Pathol; 2014 Nov; 67(11):932-7. PubMed ID: 25031389
[TBL] [Abstract][Full Text] [Related]
3. Epithelial gp130/Stat3 functions: an intestinal signaling node in health and disease.
Ernst M; Thiem S; Nguyen PM; Eissmann M; Putoczki TL
Semin Immunol; 2014 Feb; 26(1):29-37. PubMed ID: 24434062
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
Rose-John S; Scheller J; Elson G; Jones SA
J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 trans-signalling in chronic inflammation and cancer.
Scheller J; Ohnesorge N; Rose-John S
Scand J Immunol; 2006 May; 63(5):321-9. PubMed ID: 16640655
[TBL] [Abstract][Full Text] [Related]
6. Blocking the IL-6-STAT3 signaling pathway: potential liver cancer therapy.
Liu Y; Lin J
Future Oncol; 2011 Feb; 7(2):161-4. PubMed ID: 21345134
[No Abstract] [Full Text] [Related]
7. New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer.
Zarogoulidis P; Yarmus L; Zarogoulidis K
Ther Deliv; 2013 Oct; 4(10):1221-3. PubMed ID: 24116905
[No Abstract] [Full Text] [Related]
8. NF-κB and the link between inflammation and cancer.
DiDonato JA; Mercurio F; Karin M
Immunol Rev; 2012 Mar; 246(1):379-400. PubMed ID: 22435567
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6--a key regulator of colorectal cancer development.
Waldner MJ; Foersch S; Neurath MF
Int J Biol Sci; 2012; 8(9):1248-53. PubMed ID: 23136553
[TBL] [Abstract][Full Text] [Related]
10. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.
Shrimali D; Shanmugam MK; Kumar AP; Zhang J; Tan BK; Ahn KS; Sethi G
Cancer Lett; 2013 Dec; 341(2):139-49. PubMed ID: 23962559
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically.
Putoczki TL; Thiem S; Loving A; Busuttil RA; Wilson NJ; Ziegler PK; Nguyen PM; Preaudet A; Farid R; Edwards KM; Boglev Y; Luwor RB; Jarnicki A; Horst D; Boussioutas A; Heath JK; Sieber OM; Pleines I; Kile BT; Nash A; Greten FR; McKenzie BS; Ernst M
Cancer Cell; 2013 Aug; 24(2):257-71. PubMed ID: 23948300
[TBL] [Abstract][Full Text] [Related]
12. The soluble Interleukin 6 receptor: generation and role in inflammation and cancer.
Chalaris A; Garbers C; Rabe B; Rose-John S; Scheller J
Eur J Cell Biol; 2011; 90(6-7):484-94. PubMed ID: 21145125
[TBL] [Abstract][Full Text] [Related]
13. [Interleukin-6 From molecular mechanisms of signal transduction to physiological properties and therapeutic targeting].
Drutskaya MS; Nosenko MA; Atretkhany KS; Efimov GA; Nedospasov SA
Mol Biol (Mosk); 2015; 49(6):937-43. PubMed ID: 26710772
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 signaling pathway in targeted therapy for cancer.
Guo Y; Xu F; Lu T; Duan Z; Zhang Z
Cancer Treat Rev; 2012 Nov; 38(7):904-10. PubMed ID: 22651903
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6: an angiogenic target in solid tumours.
Middleton K; Jones J; Lwin Z; Coward JI
Crit Rev Oncol Hematol; 2014 Jan; 89(1):129-39. PubMed ID: 24029605
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization.
Izumi-Nagai K; Nagai N; Ozawa Y; Mihara M; Ohsugi Y; Kurihara T; Koto T; Satofuka S; Inoue M; Tsubota K; Okano H; Oike Y; Ishida S
Am J Pathol; 2007 Jun; 170(6):2149-58. PubMed ID: 17525280
[TBL] [Abstract][Full Text] [Related]
17. Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases.
Wang K; Grivennikov SI; Karin M
Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii100-3. PubMed ID: 23253923
[TBL] [Abstract][Full Text] [Related]
18. The IL-6 feed-forward loop: a driver of tumorigenesis.
Chang Q; Daly L; Bromberg J
Semin Immunol; 2014 Feb; 26(1):48-53. PubMed ID: 24613573
[TBL] [Abstract][Full Text] [Related]
19. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS
Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]